Clinical Trial

China Registry for Genetic / Metabolic Liver Diseases

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 27, 2017 (before its estimated April 28, 2022 completion). Its status may not reflect the trial's current state.
Summary
CR-GMLD registry started on June 13, 2015 to collect cases of genetic/metabolic liver diseases from tertiary or secondary hospitals in mainland China. Demographics, diagnosis, laboratory test results, family history and prescriptions were recorded. Patients' whole blood and serum were collected for genetic testing and future researches. These patients will be followed-up every six to twelve months.
Trial Details
NCT Number NCT03131427
Lead Sponsor Beijing Friendship Hospital
Collaborators: Beijing YouAn Hospital, Henan Provincial People's Hospital, Beijing Ditan Hospital, Hebei Medical University Third Hospital, Peking University First Hospital, Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital, Nanfang Hospital, Southern Medical University, Logistics University of Chinese People's Armed Police Forces, Beijing Anzhen Hospital, West China Second University Hospital, Jinshan Hospital Fudan University, Fudan University
Conditions Genetic/Metabolic Liver Diseases
Enrollment 20,000 participants
Start Date 2015-06-13
Primary Completion 2022-04-28 (estimated)
Study Completion 2027-04-28 (estimated)
Updated on ClinicalTrials.gov 2017-04-27